Founded Year
2012Stage
Acq - Pending | AcquiredTotal Raised
$139.6MAbout eFFECTOR Therapeutics
eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR's approach provides a real opportunity to bring new medicines to patients in need.
eFFECTOR Therapeutics Headquarter Location
11180 Roselle Street Suite A
San Diego, California, 92121,
United States
858-442-4861
Latest eFFECTOR Therapeutics News
Expert Collections containing eFFECTOR Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
eFFECTOR Therapeutics is included in 4 Expert Collections, including Pharma Startups.
Pharma Startups
6,549 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Cancer Therapeutics
1,179 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Biopharmaceuticals
5,881 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
eFFECTOR Therapeutics Patents
eFFECTOR Therapeutics has filed 28 patents.
The 3 most popular patent topics include:
- Transcription factors
- Gene expression
- Proteins
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/23/2019 | 9/28/2021 | Transcription factors, Experimental cancer drugs, Gene expression, MicroRNA, Human proteins | Grant | |
Application Date | 10/23/2019 | ||||
|---|---|---|---|---|---|
Grant Date | 9/28/2021 | ||||
Title | |||||
Related Topics | Transcription factors, Experimental cancer drugs, Gene expression, MicroRNA, Human proteins | ||||
Status | Grant |
